Use of Gemtuzumab Ozogamicin for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) or Acute Promyelocytic Leukemia (APL) in an Expanded Access Setting at Our Cancer Consortium
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Kelda M Gardner, Kathleen Shannon Dorcy, Rachele O'Leary, Donelle Rizzuto, Roland B. Walter, Carole Shaw, Sunny So, Paul C. Hendrie, Bart L Scott, Mary Beth M. Percival, Anna B. Halpern, Ryan D. Cassaday, Janis L. Abkowitz, Bethany Murphy, Niall Curley, Cody Hammer, Heather Smith, Gabrielle A Zecha, Frederick R. Appelbaum, Soheil Meshinchi, Colleen Delaney, Todd M Cooper, Katherine Tarlock, Elihu H. Estey, Pamela S. Becker
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2910767486